跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MAGNEVIST gadopentetate dimeglumine 9.38g/20mL injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
MAGNEVIST gadopentetate dimeglumine 9.38g/20mL injection vial
Approved
STANDARD
MAGNEVIST gadopentetate dimeglumine 9.38g/20mL injection vial
Bayer Australia Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
2fce5ac7cf8fda21
Company
Bayer Australia Ltd
Type
Standard
Approval Details
Approval Id
2fce5ac7cf8fda21
Product Name
MAGNEVIST gadopentetate dimeglumine 9.38g/20mL injection vial
Artg Id
48495
Artg Name
MAGNEVIST gadopentetate dimeglumine 9.38g/20mL injection vial
Sponsor
Bayer Australia Ltd
Company Detail Path
/organization/bayer-australia-ltd
Artg Date
1994-05-04
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
2fce5ac7cf8fda21
Type
Standard
Back to TGA Approvals
